YvonneMarieMoweryMD
Radiation Oncology • Pittsburgh, PACentral Nervous System Cancer, Head & Neck, Melanoma, Skin Cancer
Associate Professor, Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh
Dr. Mowery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5230 Centre Ave
Pittsburgh, PA 15232Phone+1 412-623-7088Fax+1 412-623-6725- Is this information wrong?
Summary
- Yvonne M. Mowery, MD, PhD, DABR is a physician scientist and an Associate Professor of Radiation Oncology at University of Pittsburgh/UPMC Hillman Cancer Center. She is a board-certified radiation oncologist, specializing in treating head and neck cancer, base of skull tumors, and skin cancer. She received her MD and PhD in Pathology at Duke University in 2012, followed by completing an Internal Medicine internship and Radiation Oncology residency at Duke University in 2017. She was the Butler Harris Assistant Professor of Radiation Oncology at Duke University through May 2023 prior to moving to UPMC Hillman Cancer Center. Her laboratory focuses on studying head and neck cancer pathogenesis and mechanisms of overcoming radiation and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC), with a particular interest in DNA damage response pathways. Yvonne previously served as the Associate Center Director for Radioimmunotherapy for the Duke Cancer Institute Center of Cancer Immunotherapy, and she was awarded a 2021 American Society for Clinical Investigation Young Physician-Scientist Award. She is the PI of an investigator-initiated phase I trial (NCT04576091) evaluating the ATR inhibitor BAY 1895344 with pembrolizumab and stereotactic body radiation therapy for recurrent HNSCC. Her research support includes a K08 Career Development Award from the National Institute of Dental and Craniofacial Research and a Damon Runyon Clinical Investigator Award.
Education & Training
Duke University HospitalResidency, Radiation Oncology, 2013 - 2017- Duke University HospitalInternship, Internal Medicine, 2012 - 2013
Duke University School of MedicineClass of 2012
Certifications & Licensure
VA State Medical License 2020 - 2024
NC State Medical License 2012 - 2024
PA State Medical License 2023 - 2024- American Board of Radiology Radiation Oncology
Clinical Trials
- PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study Start of enrollment: 2018 Jun 19
- Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx Start of enrollment: 2021 Apr 12
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer Start of enrollment: 2022 Jul 06
- Join now to see all
Publications & Presentations
PubMed
- Health Care Cost Reductions with Machine Learning-Directed Evaluations during Radiation Therapy - An Economic Analysis of a Randomized Controlled Study.Eric L Eisenstein, Samantha M Thomas, Neville C W Eclov, Nicole H Dalal, Mary Malicki, Stacey Shields, Alyssa Cobb, Donna Niedzwiecki, Jessica D Tenenbaum, Divya Nates...> ;NEJM AI. 2024 Apr 1
- Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.Diana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, Rico J Castillo, Alex M Bassil, Joshua Chen, Madison L Ravotti, Eric S Xu, Jonathan E Himes, Andrea R Daniel, Ta...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.Mowery, Y.> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Mar 1
- Join now to see all
Press Mentions
- Duke in the News: Political Polarization, COVID Evolution, and a New Human OrganOctober 23rd, 2020
Duke Cancer Researcher Receives Outstanding Investigator AwardMarch 17th, 2016
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck CancerMarch 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
